+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-27Number of Pages: 85

Genome Engineering Market: By Technology (CRISPR, TALEN, ZFN and Other Technologies), by Application (Cell-line Engineering, Animal Genome Engineering, Plant genome engineering and Other Application), by End-user (Pharmaceutical and Biotechnology Companies, Academics and Clinical Research Organizations): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Genome engineering is the synthetic modification of chromosomal DNA by using molecular scissors. Current advances in genome engineering are based on the programmable nucleases that can modify eukaryotic genomes. The global genome engineering market report includes the current and future prospects of the market with an elaborate executive summary, including a market snapshot on various segments and sub-segments. This section also provides the overall information and data analysis of the global genome engineering market with respect to the leading market segments based on type of technology, application, end-user and geography.

The market overview section of the report includes qualitative analysis of the overall genome engineering market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players has also been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

The global genome engineering market has been segmented on the basis of technology, application, end-user and geography. Based on technology, the genome engineering market has been categorized into two major segments: Clustered regularly-interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc finger nuclease (ZFN) and other technologies, while the other technologies include antisense technology and recombinant AAV mediated genome engineering. Based on application, market has been segmented into Cell-line Engineering, Animal Genome Engineering, Plant genome engineering and Other Application. Based on end-user, the market is segmented into Pharmaceutical and Biotechnology Companies, Academics and Clinical Research Organizations. Market revenue in terms of USD million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.

Geographically, the genome engineering market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia Pacific comprises China, India, and Rest of Asia Pacific. Rest of World comprises of Latin America, Middle-East & Africa. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the genome engineering market. The report also profiles major players in the genome engineering market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Sangamo Biosciences, Inc., Lonza Group Ltd., Horizon Discovery Group Plc, and Integrated DNA Technologies, Inc.

Global Genome Engineering Market, by Technology

  • Clustered regularly interspaced short palindromic repeats (CRISPR)
  • Transcription activator-like effector nuclease (TALEN)
  • Zinc Finger Nuclease (ZFN)
  • Other Technologies

Global Genome Engineering Market, by Application

  • Overview
  • Cell Line Engineering
  • Animal Genome Engineering
  • Plant Genome Engineering
  • Other Application

Global Genome Engineering Market, by End-User

  • Overview
  • Pharmaceutical and Biotechnology Companies
  • Academics
  • Clinical Research Organizations 

Global Genome Engineering Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle-East & Africa


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Global Genome Engineering Market– Industry Analysis
3.1 Introduction
3.2 Market Drivers
     3.2.1 Increased funding in Genomic research 
     3.2.2 Investment by Pharmaceutical Companies for developing new treatments
     3.2.3 Rising demand for synthetic genes
3.3 Market Restraints
     3.3.1 Ethical Issues
     3.3.2 Stringent regulatory framework 
     3.3.3 Negative public perception related to genetic research
3.4 Opportunities
     3.4.1 Technological improvements for wide range of applications
3.5 Porter’s Five Force Analysis of the Global Genome Engineering Market
     3.5.1 Bargaining power of suppliers
     3.5.2 Bargaining power of buyers
     3.5.3 Threat of substitutes
     3.5.4 Threat of new entrants
     3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Genome Engineering Market, by Geography
3.7 Competitive Landscape
     3.7.1 Market Share Analysis: Global Genome Engineering Market, 2014 (Value %)

Chapter 4 Global Genome Engineering Market, by Technology
4.1 Global Genome Engineering Market Revenue, by Technology, 2013–2023, (US$ Mn)

Chapter 5 Global Genome Engineering Market, by Application
5.1 Global Genome Engineering Market Revenue, By Application, 2013–2023, (US$ Mn)

Chapter 6 Global Genome Engineering Market, by End-User
6.1 Global Genome Engineering Market Revenue, By End-User, 2013–2023, (US$ Mn)

Chapter 7 Global Genome Engineering Market, by Geography
7.1 Global Genome Engineering Market Revenue, by Geography, 2013 – 2023 (USD Mn)
7.2 North America Genome Engineering Market Revenue, 2013 - 2023, (USD Mn)
7.3 Europe Genome Engineering Market Revenue, 2013 - 2023, (USD Mn)
7.4 Asia-Pacific Genome Engineering Market Revenue, 2013 - 2023, (US$ Mn)
7.5 Rest of World Genome Engineering Market Revenue, 2013 - 2023, (US$ Mn)

Chapter 8 Recommendations

Chapter 9 Company Profiles
9.1Applied StemCell, Inc. 
     9.1.1 Company Overview
     9.1.2 Product Portfolio
     9.1.3 Recent Developments
9.2 Horizon Discovery Group Plc
     9.2.1 Company Overview
     9.2.2 Financial Overview
     9.2.3 Product Portfolio
     9.2.4 Recent Developments
9.3 Sigma-Aldrich Corporation
     9.3.1 Company Profile
     9.3.3 Product Portfolio
     9.3.3 Recent Developments
9.4 Genscript USA Inc.
     9.4.1 Company Overview
     9.4.2 Product Portfolio
     9.4.3 Recent Developments
9.5 Sangamo Biosciences, Inc.
     9.5.1 Company Overview
     9.5.2 Financial Overview
     9.5.3 Product Portfolio
     9.5.4 Recent Developments
9.6 Integrated DNA Technologies, Inc
     9.6.1 Company Overview
     9.6.2 Financial Overview
     9.6.3 Product Portfolio
     9.6.4 Recent Developments
9.7 Lonza Group Ltd.
     9.7.1 Company Overview
     9.7.2 Financial Overview
     9.7.3 Product Portfolio
     9.7.4 Recent Developments
9.8 New England Biolabs, Inc.
     9.8.1 Company Overview
     9.8.2 Financial Overview
     9.8.3 Product Portfolio
     9.8.4 Recent Developments
9.9 Thermo Fisher Scientific, Inc
     9.9.1 Company Overview
     9.9.2 Financial Overview
9.9.3Product Portfolio
     9.9.4 Recent Developments
9.10 Origene Technologies, Inc.
     9.10.1 Company Overview
     9.10.2 Financial Overview
9.10.3Product Portfolio
     9.10.4 Recent Developments
9.11 Transposagen Biopharmaceuticals, Inc..
     9.11.1 Company Overview
     9.11.2 Financial Overview
     9.11.3Product Portfolio
     9.11.4 Recent Developments

Genome engineering refers to the strategies and techniques implemented for the modification of target genetic information of any living organism. Current advances in genome engineering is based on the programmable nucleases.

The global genome engineering market is anticipated to grow at a faster rate due to Increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development. Advances in CRISPR-Cas9 genome engineering would positively impact future market growth. For instance, in November 2015, a new CRISPR technology was developed by scientists at the University of Massachusetts Medical School for cell analysis of large population and has most of the applications in gene therapy. The factors hampering the market growth are ethical issues like human germ-line modification, stringent regulatory framework and negative public perception related to genetic research.

The global genome engineering market has been estimated based on technologies, application, end-user and geography. Based on technology, the global market has been segmented into Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN) and other technologies. CRISPR technology held the largest share of the market in 2014 and would continue to dominate the market during the forecast period. The segment would also grow at highest CAGR during the forecast period. Based on application, the global genomic engineering market has been segmented into cell-line engineering, animal genome engineering, plant genome engineering and other applications. Cell-line engineering held the largest share of the market in 2014 and would continue to dominate the market during the forecast period. The segment would also grow at highest CAGR during the forecast period. Based on end-users, the global genomic engineering market has been segmented into Pharmaceutical and Biotechnology Companies, Academics and Clinical Research Organizations (CRO). The end-user segment, Pharmaceutical and Biotechnology Companies held the largest share of the market in 2014 and would continue to dominate the market during the forecast period. The Academics segment would also grow at highest CAGR during the forecast period. 

Geographically, the genome engineering market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). North America held the largest share of the genome engineering market in 2014, followed by Europe. North America covers major share due to high funding in genomic research and all the key players have their headquarters in the U.S. Asia Pacific was identified as the third largest market for genome engineering in 2014 and the region is expected to register fastest CAGR during the forecast period. Academic research spending would also propel the market in near future.

The key players in genome engineering market are Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Sangamo Biosciences, Inc., Lonza Group Ltd., Horizon Discovery Group Plc, Integrated DNA Technologies, Inc., are among the others.  Thermo Fisher Scientific, Inc was identified as the leading player in the global Genome engineering market in 2014. 

 

global-genome-engineering-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries